Inflammatory Responses Recruiting Phase 3 Trials for Methylprednisolone (DB00959)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03229538STeroids to REduce Systemic Inflammation After Infant Heart SurgeryTreatment